Asset Details
Do you wish to reserve the book?
The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures
Do you wish to request the book?
The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
The Impact of Education and Prescribing Guidelines on Opioid Prescribing for Breast and Melanoma Procedures
2019
Overview
Background
Excessive opioid prescribing is common in surgical oncology, with 72% of prescribed opioids going unused after curative-intent surgery. In this study, we sought to reduce opioid prescribing after breast and melanoma procedures by designing and implementing an intervention focused on education and prescribing guidelines, and then evaluating the impact of this intervention.
Methods
In this single-institution study, we designed and implemented an intervention targeting key factors identified in qualitative interviews. This included mandatory education for prescribers, evidence-based prescribing guidelines, and standardized patient instructions. After the intervention, interrupted time-series analysis was used to compare the mean quantity of opioid prescribed before and after the intervention (July 2016–September 2017). We also evaluated the frequency of opioid prescription refills.
Results
During the study, 847 patients underwent breast or melanoma procedures and received an opioid prescription. For mastectomy or wide local excision for melanoma, the mean quantity of opioid prescribed immediately decreased by 37% after the intervention (
p
= 0.03), equivalent to 13 tablets of oxycodone 5 mg. For lumpectomy or breast biopsy, the mean quantity of opioid prescribed decreased by 42%, or 12 tablets of oxycodone 5 mg (
p
= 0.07). Furthermore, opioid prescription refills did not significantly change for mastectomy/wide local excision (13% vs. 14%,
p
= 0.8), or lumpectomy/breast biopsy (4% vs. 5%,
p
= 0.7).
Conclusion
Education and prescribing guidelines reduced opioid prescribing for breast and melanoma procedures without increasing the need for refills. This suggests further reductions in opioid prescribing may be possible, and provides rationale for implementing similar interventions for other procedures and practice settings.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
Analgesics, Opioid - therapeutic use
/ Biopsy
/ Breast
/ Breast Neoplasms - pathology
/ Drug Prescriptions - standards
/ Female
/ Health Services Research and Global Oncology
/ Humans
/ Inappropriate Prescribing - prevention & control
/ Mastectomy - adverse effects
/ Medicine
/ Melanoma
/ Oncology
/ Opioids
/ Pain, Postoperative - diagnosis
/ Pain, Postoperative - drug therapy
/ Pain, Postoperative - etiology
/ Practice Guidelines as Topic - standards
/ Practice Patterns, Physicians' - standards
/ Surgery
/ Tablets
